Skip to main content
Premium Trial:

Request an Annual Quote

Faking the Golgi

Researchers led by Rensselaer Polytechnic Institute's Robert Linhardt developed a prototype of an artificial Golgi complex based on a digital microfluidic chip. The researchers then used the chip to modify heparan sulfate chains. "This represents the first enzymatic modification of an immobilized substrate in a digital microfluidic device and a critical first step in the creation of an artificial Golgi," the researchers write.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.